Showing 4851-4860 of 21484 results for "".
- Central Precocious Puberty Guideline Favors Observation and Selective Testinghttps://reachmd.com/news/central-precocious-puberty-guideline-favors-observation-and-selective-testing/2488553/Key Takeaways The Endocrine Society’s first clinical practice guideline on central precocious puberty provided 10 recommendations and framed diagnosis and treatment around observation and individualized care. The guideline described two observation pathways: girls wi
- Galderma EADV Data to Explore Nemolizumab, Acne, and Fragile Skinhttps://reachmd.com/news/galderma-eadv-data-to-explore-nemolizumab-acne-and-fragile-skin/2488562/Galderma announced it will be presenting 19 abstracts, including 2 oral presentations, at the 2026 European Academy of Dermatology and Venereology (EADV) Congress, with research spanning inflammatory skin diseases, sensitive and fragile skin, skin longevity, and acne. <
- Medicare Part D Anticancer Drug Appeals Overturned 1 in 5 Timeshttps://reachmd.com/news/medicare-part-d-anticancer-drug-appeals-overturned-1-in-5-times/2488549/Key Takeaways In second-level Medicare Part D appeals for denied anticancer medications, non–medically accepted indications or off-label use were the most common denial category at 68.9%. Only about one-fifth of second-level anticancer medication appeals received a f
- Science of Skin Summit: AI in Medicine Requires More Than Knowing Which Model Scores Besthttps://reachmd.com/news/science-of-skin-summit-ai-in-medicine-requires-more-than-knowing-which-model-scores-best/2488531/Artificial intelligence models are evolving so rapidly that clinicians may struggle to determine which tools they can trust, but choosing the model that performs best on a standardized test may not provide the answer. Speaking at the Science of Skin Summit, Roxana Daneshjou, MD, PhD, discu
- Science of Skin Summit Talk Explores AI Changing the Patient-Physician Relationship in Longevity Medicinehttps://reachmd.com/news/science-of-skin-summit-talk-explores-ai-changing-the-patient-physician-relationship-in-longevity-medicine/2488528/Artificial intelligence may not replace physicians, but it is already changing the balance of knowledge between physicians and their patients, according to Hillary Lin, MD, Co-founder and CEO of CareCore.
- CT Clues Distinguish Pseudomonas From Aspergillosishttps://reachmd.com/news/ct-clues-distinguish-pseudomonas-from-aspergillosis/2488542/Key Takeaways At a single tertiary center in Seoul, blinded chest CT review in immunocompromised patients found that approximately one-third of Pseudomonas aeruginosa pneumonia cases were read as invasive pulmonary aspergillosis. Pseudomonas aeruginosa pneumonia ofte
- Lung Transplant Linked to Better 1-Year Survival in NSCLChttps://reachmd.com/news/lung-transplant-linked-to-better-1-year-survival-in-nsclc/2488543/Key Takeaways Among selected adults with medically refractory, lung-limited stage IV NSCLC and respiratory failure, lung transplant was associated with higher 1-year survival than medical management alone. Early posttransplant survival in the NSCLC transplant cohort
- Difficult Psoriasis Cases Highlight Systemic Disease, Combination Therapy, and Precision Treatment at Science of Skin Summithttps://reachmd.com/news/difficult-psoriasis-cases-highlight-systemic-disease-combination-therapy-and-precision-treatment-at-science-of-skin-summit/2488530/Modern psoriasis management increasingly requires dermatologists to look beyond visible plaques and consider the systemic disease, individual comorbidities, treatment history, and potentially even a patient's molecular profile.
- FDA Approves First Treatment for Ataxia-Telangiectasiahttps://reachmd.com/news/fda-approves-first-treatment-for-ataxia-telangiectasia/2488536/The US Food and Drug Administration (FDA) has approved Aqneursa (levacetylleucine; IntraBio) for the treatment of adults and pediatric patients with ataxia-telangiectasia (A-T) who weigh at least 15 kg, providing the first FDA-approved treatment for the rare multisystem disorder. A-T is pr
- Expert Consensus Defines Best Practices for Pseudofolliculitis Barbaehttps://reachmd.com/news/expert-consensus-defines-best-practices-for-pseudofolliculitis-barbae/2488539/A new expert consensus study published online in JAMA Dermatology outlines best practices for diagnosing and managing pseudofolliculitis barbae (PFB), including hair removal modification, medical therapy, procedural treatment, and occupational considerations.